|
Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cystectomy: Survival results from a prospective, randomized trial (LEA AUO AB 25/02). |
|
|
Honoraria - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; MSD; Novartis; Pfizer; Roche |
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche |
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Ferring; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; Takeda |
|
|
Travel, Accommodations, Expenses - Janssen-Cilag; MSD |
|
|
Honoraria - Dendreon; Hexal; Janssen Oncology; Myriad Genetics; Sandoz; Sanofi |
Consulting or Advisory Role - Myriad Genetics; Novartis; Sanofi |
|
|
Honoraria - Amgen; Astellas Pharma; Bayer; Dendreon; Ipsen; Janssen; Sanofi; Takeda |
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Dendreon; Ipsen; Janssen; Sanofi; Takeda |
Research Funding - Astellas Pharma; Bayer; Sanofi |
|
|
Travel, Accommodations, Expenses - Takeda |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Farco-Pharma |
|
|
Research Funding - Bayer (Inst); Biotest (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |